AI English summary of an SEC filing — figures as filed
The company said it notified its named executive officers on November 12, 2024 that the term of the Agreements Regarding Change in Control was extended through December 31, 2026.
Key points
AI summaryThe company said it notified its named executive officers on November 12, 2024 that the term of the Agreements Regarding Change in Control was extended through December 31, 2026.
The company said that under the existing Agreements, if it gives notice of extension before the Expiration Date (December 31, 2024), the agreement term continues through the second anniversary of the Expiration Date.
The company disclosed in this 8-K under Item 5.02 matters relating to the Agreements Regarding Change in Control with the named executive officers it had previously reported.
The company listed November 12, 2024 as the date of earliest event reported on this Form 8-K, and signed the report on November 15, 2024.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Abbott Extends Change-in-Control Agreement Term for Executives
The company said it notified its named executive officers on November 12, 2024 that the term of the Agreements Regarding Change in Control was extended through December 31, 2026.
Source · Based on the filing body and exhibits
Existing Agreement Extension Notice Terms and Expiration Date
The company said that under the existing Agreements, if it gives notice of extension before the Expiration Date (December 31, 2024), the agreement term continues through the second anniversary of the Expiration Date.
Source · Based on the filing body and exhibits
Contracts Covered Under Item 5.02 Disclosure
The company disclosed in this 8-K under Item 5.02 matters relating to the Agreements Regarding Change in Control with the named executive officers it had previously reported.
Source · Based on the filing body and exhibits
Report Date and Filing Details
The company listed November 12, 2024 as the date of earliest event reported on this Form 8-K, and signed the report on November 15, 2024.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…